TrialClinical drug investigation2014

Tolerability and pharmacokinetics of lobeglitazone, a novel peroxisome proliferator-activated receptor-γ agonist, after a single oral administration in healthy female subjects.

Min Kyu Park et al.PubMed ↗Publisher ↗

No numbers read from the abstract.